Concord Biotech informs about investor’s presentation

14 Feb 2025 Evaluate
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has informed that it enclosed ‘INVESTOR’S PRESENTATION’ on Financial Results for the Third Quarter and Nine Months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.


Concord Biotech Share Price

1015.90 1.85 (0.18%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×